Correlation Between Karuna Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Karuna Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Karuna Therapeutics and Pliant Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Karuna and Pliant is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Karuna Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Karuna Therapeutics is expected to under-perform the Pliant Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Karuna Therapeutics is 1.52 times less risky than Pliant Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Pliant Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,700 in Pliant Therapeutics on August 26, 2024 and sell it today you would lose (402.00) from holding Pliant Therapeutics or give up 23.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Karuna Therapeutics vs. Pliant Therapeutics
Performance |
| Timeline |
| Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Pliant Therapeutics |
Karuna Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karuna Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Karuna Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
| Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |